Navigation Links
Access Pharmaceuticals Provides Update on ProLindac(TM)Clinical Development Plan
Date:9/10/2009

DALLAS, Sept. 10 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), provided an update today on the Company's clinical development plan for ProLindac, a novel DACH platinum drug that has shown to be active in many solid tumor types in human clinical studies. Access' clinical development team recently met with its partners Aosaikang Medicinal Group (ASK) in Nanjing, China and JCOM, Ltd. ("JCOM") in Seoul, Korea, together with key opinion leaders in oncology indications to discuss the protocols for the three planned ProLindac combination studies. Access and its partners are finalizing development plans and protocols for clinical trials strategically designed to examine ProLindac in combination with gemcitabine and/or taxol in hepatocellular carcinoma (a form of liver cancer), pancreatic cancer and recurrent ovarian cancer.

Access previously announced positive safety and efficacy results from its Phase 2 monotherapy clinical study of ProLindac(TM) in late-stage, heavily pretreated ovarian cancer patients. In this study, 66% of patients who received the highest dose achieved clinically meaningful disease stabilization according to

SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Access Pharmaceuticals to Present at the Rodman & Renshaw Annual Healthcare Conference
2. NuAire Laboratory Economic Stimulus Package -- Free Accessories or Factory Options
3. One of the Nation's Leading Analytical Testing Laboratories is Now Easier to Access -- Pace Analytical Launches New Web Site to Showcase Its Three Business Divisions
4. Understanding Managed Markets: Effective Market Research Structures & Activities to Maximize Payer Access & Insights
5. Access Pharmaceuticals CEO Interviewed on Financial Website
6. Access Pharmaceuticals Announces Granting of Two US Patents for MuGard(TM)
7. FDA Clears Boston Scientifics SpyScope(R) Access and Delivery Catheter for Use in Endoscopic Procedures Throughout Pancreatico-Biliary System
8. Reorganizational Healing Provides Access to Greater Quality of Life, Reduced Stress
9. Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China
10. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
11. Ochsner and LSUHSC Partner to Provide Better Local Access to Comprehensive Cancer Care

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...A, Md., Nov. 19 Spherix ...technology for diabetes therapy, and a provider of...ood, supplement, biotechnology and pharmaceutical ...s Annual Meeting of Shareholders. ,, At the mee...: SPEX ) elected the following members to the Boa...
(Date:11/19/2009)...MUNSTER, Germany, November 19 MONI...n November 16th, 2009 Flibanserin in the,indicatio...n Parkinson,s,disease for orphan drug status desig...Levodopa-induced dyskinesia is a complication of t...a serious burden to some of those,affected, since ...
(Date:11/19/2009)... Top LASIK surgeons and recognized refracti...LASIK Surgeons made brought their fellow surgeons ...rrection surgery, cataract surgery, and ophthalmol...Academy of Ophthalmology (AAO) annual meeting in S...r. Shachar Tauber, Dr. David Huang, MD, Dr. Randy ...
(Date:11/19/2009)... InSound is honored by latest award for rev... Newark, CA (PRWEB) November 16, 2009 -- Popular S...le” hearing aid from InSound Medical a winne... the Health category.    Chose... reside deep in the hearing canal for up to four m...
Breaking Biology Technology:Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3
...tar,Therapeutics (Nasdaq: NKTR ) will announce it...rch 31, 2008 on Wednesday, May 7, 2008, after the,...n, president and chief,executive officer, will hos... Time (ET)., Investors can access the press relea... call through a link that is posted on the Investo...
... BTV8 vaccine released to supply Northern ...therlands, April 30 ,Intervet/Schering-Plough Anim...f Bovilis BTV8 vaccine against bluetongue to suppl...ombining after the acquisition in 2007 the,strengt...s not only the,world market leader in the producti...
... Squibb,Company (NYSE: BMY ) invites investors an... annual meeting with stockholders at 10 a.m. ET on...er and board items to be,transacted, senior execut...ess., For information on how to listen to the web...the Bristol-Myers Squibb website at, http://www.bm...
Other Biology Technology:Nektar to Announce Q1 2008 Financial Results on Wednesday, May 7, 2008, After Close of U.S.-Based Financial Markets 2Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 2Intervet/Schering-Plough Animal Health Outlines Strength of the Combination 3
(Date:11/22/2009)...ch Centre, a partnership of the University of Brit...stal Health Research Institute, have uncovered new...lls die following a stroke, as well as a possible ...udy were recently published online in Nature Medi...ntinue to die even after blood flow has been resto...
(Date:11/20/2009)...ead studies about the health benefits of having a ...lar level, where amino acids known as cysteines ar...when paired up with other cysteines. , Now, rese...colleagues in Belgium, have discovered a new antio...research appears in the Nov. 20 issue of the journ...
(Date:11/20/2009)...09) Scientists from the Marine Biogeochemistry an...earch Laboratory (NRL) organized and led a team of... expedition to initiate methane hydrate exploratio...riation of sediment contribution to Arctic climate... Polar Sea as a research platform, three cross-she...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Saving the single cysteine: New antioxidant system found 2International expedition investigates climate change, alternative fuels in Arctic 2Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 1Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 2Echo Therapeutics Initiates Clinical Study of its New One Piece Symphony 28TM 29 tCGM Biosensor in Type 1 and Type 2 Diabetic Patients 5982 3Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 1Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 2Sarnova Acquires Metropolitan Medical to Expand Portfolio of Specialty Health Care Products 5980 3Codexis Names Fernando Valle Research Fellow 5978 1Codexis Names Fernando Valle Research Fellow 5978 2
...f problems is among the greatest challenges to the...ion alone is becoming more problematic in the worl... sources, such as polluted rivers, lakes and groun...lated," says Bruce Rittmann, director of the Cente... Institute at ASU. "For example, most of the pollu...
...,s role in controlling appetite and weight, resear...ave shown that reducing levels of fatty acids in t...obese. Their results suggest that restoring fatty-... treat obesity. The study, published in the Januar... led by Dr. Luciano Rossetti, director of the Diab...
...ood pollinators, especially in species-rich biodiv...roceedings of the National Academy of Science (PNA... the University of Calgary and Tiffany Knight, Ph....ciences at Washington University in St. Louis, and...global analysis of more than 1,000 pollination stu...
Other Biology News:Earth Rx: A microbial biotechnology prescription for global environmental health 2Earth Rx: A microbial biotechnology prescription for global environmental health 3Study by Einstein researchers could lead to a novel strategy for treating obesity 2Study: Competition for sex is a 'jungle out there' 2
Bovine IgG2 ELISA Kit from Bethyl Laboratories
Dog IgE ELISA Kit from Bethyl Laboratories
PCP ELISA Kit, Single from Bio-Quant Inc.
...opment ,Antibody Titer and Optimal Conditions Anal... and Tissues ,Double Antibody Labeling of Cells an...ogold, and Fluorescent detection ,Light, Fluoresce...n Transgenic Animals ,Hundreds of Specialty Marker...
Biology Products: